Parenteral Nutrition for Marrow Transplant Recipients: Evaluation of an Increased Nitrogen Dose

The use of total parenteral nutrition in bone marrow transplant (BMT) recipients is well recognized. These patients as a result of treatment with chemotherapy and immunosuppressive agents undergo catabolic stress. The metabolic effect of an increased nitrogen dose during total parenteral nutrition (TPN) was studied in 28 BMT patients. Patients were given TPN formulas providing a nitrogen intake of either 267 ± 44 mg of N/kg/d or 330 ± 60 mg of N/kg/d. Total calories, nonprotein and protein, were held constant at 40 kcal/ kg/d for all patients. Data was collected for three periods posttransplant beginning at 3 days posttransplant through day 16. Both study TPN formulas improved patient weight and TIBC values over baseline. Nitrogen balance (NB) values were not significantly different at any study period. However, an overall group effect favored the H‐N formula (p < 0.01). BMT patients undergo catabolic stress which was reflected by average values of 24‐hour urine urea nitrogen increasing from 8.1 ± 4 g/d at baseline to 19.8 ± 7.2 g/d at period 3 (p < 0.01). The H‐N formula did not differentially increase blood urea nitrogen or serum creatinine levels. Metabolic cart measures also showed no increase in metabolic rate, oxygen consumption, carbon dioxide production, or percent contribution of protein to total metabolic expenditure. Providing a caloric intake of 40 kcal/ kg/d was excessive, where 30 to 35 kcal/kg/d would meet metabolic demands. Pertinent clinical outcomes including length of stay, relapse rate, and survival were monitored, but no conclusions could be drawn in this study. The H‐N formula was more effective in reducing loss of lean body mass without causing detrimental metabolic effects in BMT patients. (Journal of Parenteral and Enteral Nutrition 15: 184–188, 1991)